PRESS RELEASE published on 05/18/2026 at 07:30, 1 month 17 days ago Informations privilégiées / Autres communiqués Sensorion nomme Fred Chereau au poste de Directeur Général, apportant son expertise en biotechnologie et thérapie génique. Amit Munshi continue en tant que Président du Conseil d'Administration Biotechnologie Thérapie Génique Sensorion Amit Munshi Fred Chereau
PRESS RELEASE published on 05/18/2026 at 07:30, 1 month 17 days ago Inside Information / Other news releases Sensorion appoints Fred Chereau as Chief Executive Officer, bringing extensive leadership experience in gene therapy and rare diseases. Amit Munshi continues as Chairman of the Board Gene Therapy Chief Executive Officer Rare Diseases Sensorion Fred Chereau
BRIEF published on 05/13/2026 at 07:35, 1 month 22 days ago Results of the Sensorion General Meeting Biotechnology General Assembly Resolutions Adopted Hearing Loss Sensory
BRIEF published on 05/13/2026 at 07:35, 1 month 22 days ago Résultats de l'Assemblée Générale de Sensorion Biotechnologie Assemblée Générale Résolutions Adoptées Sensorion Pertes Auditives
PRESS RELEASE published on 05/13/2026 at 07:30, 1 month 22 days ago Inside Information / Other news releases Sensorion releases results of Combined General Meeting resolutions. All recommended resolutions adopted with 77.83% capital presence. Details available on website Shareholders General Meeting Resolutions Sensorion Hearing Loss
PRESS RELEASE published on 05/13/2026 at 07:30, 1 month 22 days ago Informations privilégiées / Autres communiqués Sensorion publie les résultats de l’Assemblée générale mixte des actionnaires et annonce l'adoption de toutes les résolutions présentées lors de l'AGM Actionnaires Assemblée Générale Résultats Sensorion Thérapies Innovantes
BRIEF published on 05/05/2026 at 07:35, 1 month 30 days ago Sensorion Participates in ASGCT Annual Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ASGCT 2026
BRIEF published on 05/05/2026 at 07:35, 1 month 30 days ago Sensorion participe à la conférence annuelle de l'ASGCT Thérapie Génique Sensorion Perte Auditive SENS-601 ASGCT 2026
BRIEF published on 05/05/2026 at 07:35, 1 month 30 days ago Sensorion is participating in the ASGCT annual conference Gene Therapy Hearing Loss SENS-601 Sensory ASGCT 2026
BRIEF published on 05/05/2026 at 07:35, 1 month 30 days ago Sensorion participe à la réunion annuelle de l'ASGCT Biotechnologie Thérapie Génique Sensorion Perte Auditive ASGCT 2026
Published on 07/03/2026 at 23:00, 14 hours 1 minute ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 15 hours 33 minutes ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 17 hours 31 minutes ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 23 hours 31 minutes ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/04/2026 at 11:01, 1 hour 59 minutes ago EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 3 hours 55 minutes ago Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 18 hours 1 minute ago PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 18 hours 5 minutes ago Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 18:14, 18 hours 46 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/03/2026 at 21:49, 15 hours 11 minutes ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 15 hours 11 minutes ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 18 hours 18 minutes ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 18 hours 24 minutes ago Disclosure of transactions in own shares from July 1 to July 3, 2026
